{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:57:36Z","timestamp":1790117856680,"version":"4.0.1"},"reference-count":44,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100005321","name":"American College of Clinical Pharmacy Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Study Objective<\/jats:title>\n                    <jats:p>Methadone is associated with QT interval prolongation and torsades de pointes. The objective of this study was to (a) determine the incidence of QT interval prolongation among patients on maintenance methadone therapy in an urban opioid treatment program (OTP), (b) compare characteristics of patients who developed methadone\u2010associated QT prolongation with those who did not develop QT prolongation, and (c) investigate the relationship between QT interval prolongation and stereospecific serum methadone and metabolite [2\u2010ethylidene\u20101,5\u2010dimethyl\u20103,3\u2010diphenylpyrrolidine (EDDP)] concentrations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Prospective study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Urban opioid treatment program (OTP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients<\/jats:title>\n                    <jats:p>\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a093 patients on maintenance methadone therapy in an urban OTP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>\n                      Patients underwent a 12\u2010lead electrocardiogram (ECG) prior to initiating methadone and again during steady\u2010state maintenance methadone therapy. In a subset (\n                      <jats:italic>n<\/jats:italic>\n                      \u00a0=\u00a043), blood was obtained to determine serum (\n                      <jats:italic>S<\/jats:italic>\n                      )\u2010 and (\n                      <jats:italic>R<\/jats:italic>\n                      )\u2010methadone and (\n                      <jats:italic>S<\/jats:italic>\n                      )\u2010 and (\n                      <jats:italic>R<\/jats:italic>\n                      )\u2010EDDP concentrations, which were compared in patients who developed Bazett\u2019s\u2010corrected QT (QTc) prolongation [\u2265470\u00a0ms (men) or \u2265480\u00a0ms (women) and\/or \u226560\u00a0ms lengthening from pretreatment value] with those who did not have QTc prolongation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>\n                      Mean [\u00b1 standard deviation (SD)] age was 36\u00a0\u00b1\u00a012\u00a0years; 73% were female, and 74% were white. QTc prolongation occurred in 14 (15.1%) patients. Patients who developed QTc prolongation were older (41\u00a0\u00b1\u00a013 vs. 35\u00a0\u00b1\u00a09\u00a0years,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.03) and had a longer pre\u2010methadone QTc compared with those who did not have QTc prolongation (429\u00a0\u00b1\u00a011 vs. 420\u00a0\u00b1\u00a020\u00a0ms, respectively,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.02). Serum (\n                      <jats:italic>S<\/jats:italic>\n                      )\u2010methadone concentrations were higher in patients with QTc prolongation compared to patients without prolongation (199\u00a0\u00b1\u00a081 vs. 128\u00a0\u00b1\u00a068\u00a0ng\/ml, respectively,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.01), whereas the difference in serum (\n                      <jats:italic>R<\/jats:italic>\n                      )\u2010methadone concentrations between the groups did not reach significance (189\u00a0\u00b1\u00a068 vs. 125\u00a0\u00b1\u00a060\u00a0ng\/ml, respectively,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.08). Serum (\n                      <jats:italic>R<\/jats:italic>\n                      )\u2010methadone concentrations correlated with QTc intervals [\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u00a0=\u00a00.15 (95% confidence interval (CI) 0.11\u20130.62,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.0009)]. The correlation between serum (\n                      <jats:italic>S<\/jats:italic>\n                      )\u2010methadone concentrations and QTc did not reach significance [\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u00a0=\u00a00.08 (95% CI \u22120.01 to 0.54,\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0=\u00a00.06)]. Serum (\n                      <jats:italic>S<\/jats:italic>\n                      )\u2010and (\n                      <jats:italic>R<\/jats:italic>\n                      )\u2010EDDP concentrations were not significantly different between the groups and did not significantly correlate with QTc intervals.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Approximately 15% of patients taking maintenance methadone therapy developed QT interval prolongation. Both serum (\n                      <jats:italic>S<\/jats:italic>\n                      )\u2010 and (\n                      <jats:italic>R<\/jats:italic>\n                      )\u2010methadone concentrations, but not (\n                      <jats:italic>S<\/jats:italic>\n                      )\u2010 or (\n                      <jats:italic>R<\/jats:italic>\n                      )\u2010EDDP, contribute to methadone\u2010associated QT prolongation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/phar.2498","type":"journal-article","created":{"date-parts":[[2020,12,21]],"date-time":"2020-12-21T02:01:26Z","timestamp":1608516086000},"page":"238-246","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Methadone\u2010associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program"],"prefix":"10.1002","volume":"41","author":[{"given":"Erika N.","family":"Titus\u2010Lay","sequence":"first","affiliation":[{"name":"Department of Pharmacy Eskenazi Health Indianapolis Indiana USA"},{"name":"College of Pharmacy Purdue University Indianapolis Indiana USA"},{"name":"College of Pharmacy, California Northstate University Elk Grove California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Jaynes","sequence":"additional","affiliation":[{"name":"College of Pharmacy Purdue University Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tomaselli Muensterman","sequence":"additional","affiliation":[{"name":"College of Pharmacy Purdue University Indianapolis Indiana USA"},{"name":"AbbVie Inc. North Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd A.","family":"Walroth","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Eskenazi Health Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Ott","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Eskenazi Health Indianapolis Indiana USA"},{"name":"College of Pharmacy Purdue University Indianapolis Indiana USA"},{"name":"School of Medicine Indiana University Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeruesenay","family":"Desta","sequence":"additional","affiliation":[{"name":"School of Medicine Indiana University Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Eskenazi Health Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Moe","sequence":"additional","affiliation":[{"name":"Sandra Eskenazi Health Mental Health Center Opioid Treatment Program Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Wilbrandt","sequence":"additional","affiliation":[{"name":"Sandra Eskenazi Health Mental Health Center Opioid Treatment Program Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2117-9463","authenticated-orcid":false,"given":"James E.","family":"Tisdale","sequence":"additional","affiliation":[{"name":"College of Pharmacy Purdue University Indianapolis Indiana USA"},{"name":"School of Medicine Indiana University Indianapolis Indiana USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192704"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.12.063"},{"key":"e_1_2_7_4_1","unstructured":"WoosleyRL HeiseCW GalloT TateJ WoosleyD RomeroKA.QTdrugs List www.CredibleMeds.org [accessed March 10 2020] AZCERT Inc. 1822 Innovation Park Dr. Oro Valley AZ 85755."},{"issue":"17","key":"e_1_2_7_5_1","first-page":"4294","article-title":"Opioid addiction, genetic susceptibility, and medical treatments: a review","volume":"20","author":"Wang S\u2010C","year":"2019","journal-title":"Int J Med Sci"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.038240"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.37573\/9781585285310.025"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-10-201305210-00008"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/add.13013"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1112"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/1715163516641136"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.113.000152"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000085057.63483.9b"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100120"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00937-6"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000167043"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2010.00628.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpdd.326"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2017.07.010"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2008.03.037"},{"key":"e_1_2_7_21_1","first-page":"353","article-title":"An analysis of the time\u2010relations of electrocardiograms","volume":"7","author":"Bazett HC","year":"1920","journal-title":"Heart"},{"key":"e_1_2_7_22_1","unstructured":"U.S. Department of Health and Human Services (DHHS) Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER).Guidance for industry. Clinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential for non\u2010antiarrhythmic drugs.Rockville MD:DHHS 2005."},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2013.804525"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2006.100180"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02549.x"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001444"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2011.610710"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2014.01.494"},{"key":"e_1_2_7_29_1","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0022-3565(24)29321-6","article-title":"Effects of cocaine and its major metabolites on the HERG\u2010encoded potassium channel","volume":"299","author":"Ferreira S","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.12.001"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200107000-00012"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/2048872616649473"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1300\/J069v24n01_05"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/10550880903436044"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.06.018"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000353"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/dar.12415"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12423"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12405"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/384078a0"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.04.027"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-016-0415-2"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.26"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.08.011"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241140-00003"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2498","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/phar.2498","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/phar.2498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T16:53:56Z","timestamp":1761065636000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/phar.2498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1002\/phar.2498"],"URL":"https:\/\/doi.org\/10.1002\/phar.2498","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"2020-08-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}